Early ribavirin for hepatitis E virus infection in patients receiving immunosuppressive therapy: a retrospective, observational study
Objective Hepatitis E virus (HEV) infections are common, self-limiting causes of acute viral hepatitis. This study aimed to analyze hepatic injury, viremia, and chronicity rates in patients with acute HEV infection receiving immunosuppressive (IS) therapy taking into account ribavirin treatment. Met...
Main Authors: | Anika Franz, Philipp A Reuken, Sura Guliyeva, Michael Rose, Katharina Boden, Andreas Stallmach, Tony Bruns |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2023-07-01
|
Series: | Journal of International Medical Research |
Online Access: | https://doi.org/10.1177/03000605231187941 |
Similar Items
-
Ledipasvir/sofosbuvir and ribavirin for the treatment of ribavirin-refractory persistent hepatitis E virus infection
by: Jennifer Gallacher, et al.
Published: (2023-01-01) -
Transcriptional Suppression of the NLRP3 Inflammasome and Cytokine Release in Primary Macrophages by Low-Dose Anthracyclines
by: Nilay Köse-Vogel, et al.
Published: (2019-12-01) -
Risk Factors for Multi-Drug Resistant Pathogens and Failure of Empiric First-Line Therapy in Acute Cholangitis.
by: Philipp A Reuken, et al.
Published: (2017-01-01) -
Effect of Sofosbuvir plus Ribavirin therapy on hepatitis C patients in Pakistan: a retrospective study
by: Zubia Jamil, et al.
Published: (2018-05-01) -
Combination therapy for chronic hepatitis C: interferon and ribavirin.
by: Christie, J, et al.
Published: (1999)